Perspective Therapeutics, Inc. (CATX) vs ClearPoint Neuro, Inc. (CLPT)
- Perspective Therapeutics, Inc. CATX 2.17 −7.26%
- ClearPoint Neuro, Inc. CLPT 9.07 −5.91%
Perspective Therapeutics, Inc. and ClearPoint Neuro, Inc. are both Medical Devices companies. ClearPoint Neuro, Inc. is the larger, with a market value of $294.1M against $267.1M — 1.1× the size. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against −66.9%. ClearPoint Neuro, Inc. has the higher net margin (−81.8% vs −28,468.0%) and the higher return on invested capital (−61.3% vs −88.4%). Across the 18 metrics below, ClearPoint Neuro, Inc. leads on 11 and Perspective Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | CATX | CLPT | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 62.61% | 56.01% |
| Operating margin | (30,619.07%) | (73.42%) | (15.03%) |
| Net margin | (28,467.97%) | (81.76%) | (20.40%) |
| Free cash flow margin | (29,630.07%) | (74.01%) | (7.24%) |
| Return on equity | (39.50%) | (226.52%) | (15.32%) |
| Return on assets | (33.14%) | (46.21%) | (19.72%) |
| Return on invested capital | (88.41%) | (61.31%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack